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ABSTRACT 
In this paper, a mathematical model for the transmission dynamics of hepatitis B virus (HBV) infection 
incorporating vaccination and treatment as control parameters is presented. The basic reproduction number, , 
as a threshold parameter, was constructed, in terms of the given model parameters, by the next generation 
method.   was numerically assessed for its sensitivity to vaccination and treatment parameters. A unique 
disease-free equilibrium state was determined, indicating possibility of control of HBV disease. The model was 
solved numerically using Runge-Kutta method of order four to evaluate the effects of vaccination and treatment 
parameters on the prevalence of the disease. The numerical results of the sensitivity analysis show that 
increasing either vaccination or treatment rate has the potential of reducing  below unity. The results of the 
numerical simulations of the model show that effective vaccination, treatment or a combination of both of them 
as a control strategy can eradicate HBV disease, with the combination being far better than either of them. 
Finally, these findings strongly suggest that high coverage of vaccination and treatment are crucial to the success 
of HBV disease control. 
 
1. Introduction 
Hepatitis B is a disease that is characterized by inflammation of the liver and is caused by infection by the 
hepatitis B virus. Hepatitis may be caused by drugs or viral agents. These viral agents include the hepatitis A, B, 
C, D, E, F, G and H viruses (WHO, 2002).        
 Hepatitis B is one of the world’s most serious health problems. More than a billion people around the world 
have serological indicators of past or present infection with hepatitis B virus (HBV). Over 300 million people are 
chronic carriers of the virus (White and Fenner (1994), Platkov et al (2001), Carriapa et al (2004), Fernandez et 
al (2006), Onuzulike and Ogueri (2007)).  
HBV infection can be transmitted from mother to child (vertical), contact with an infected person (horizontal 
transmission), sexual contact (homosexual and heterosexual transmission) with infected partners, exposure to 
blood or other infected fluids and contact with HBV contaminated instruments (WHO, 2002). 
 HBV control measures include vaccination, education, screening of blood and blood products; and treatment 
(CDC, 2005). 
Epidemiological models help to capture infection or disease transmission mechanisms in a population in a 
mathematical frame-work in order to predict the behavior of the disease spread through the population. 
Mathematical models have become important tools in analyzing the spread and control of infectious diseases. 
Understanding the transmission characteristics of infectious diseases in communities, regions and countries in 
mathematical frame works can lead to better approaches to decreasing the transmission of these diseases 
(Anderson and May, 1991). 
R e c e n t l y ,  mathematical models have been used to study the transmission dynamics of HBV in various 
communities, regions and countries. Anderson and May (1991) used a simple deterministic, compartmental 
mathematical model to study the effects of carriers on the transmission of HBV. Anderson et al (1992) and 
Williams et al (1996) presented models of sexual transmission of HBV, which include heterogeneous mixing 
with respect to age and sexual activity. Edmunds et al (1993) investigated the relation between the age at 
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infection with HBV and the development of the carrier state. Medley et al (2001) proposed a model to show that 
the prevalence of infection is largely determined by a feedback mechanism that relates the rate of transmission, 
average age at infection and age-related probability of developing carriage following infection. Thornley et al 
(2008) applied the model of Medley et al (2001) to predict chronic hepatitis B infection in New Zealand. The 
prevalence of HBV in developing countries is different from that in developed countries, since it appears that the 
rate of transmission in childhood is the major determinant of the level of HBV endemicity and little is known on 
the rates and patterns of sexual contact in developing countries (Edmunds et al, 1996c). Mclean and Blumberg 
(1994) and Edmunds et al (1996a) studied models of HBV transmission in developing countries and Williams et 
al  (1996) described a model of HBV in UK. Zou et al (2009) proposed a mathematical model to investigate the 
transmission dynamics and prevalence of HBV in mainland China. The model is formulated from that of Medley 
et al (2001) based on the characteristics of HBV in China. 
Public health policy on the design of various HBV control programs has benefitted a lot from the 
recommendations of the previous mathematical modellers and much success has been recorded. However, 
available data in various regions on the prevalence of HBV infection shows a slow pace of control (WHO, 
2009). Much still needs to be done until HBV infection is eradicated from the global community. 
The model by Zou et al (2009) forms the motivation for this study. In their work, a mathematical model was 
proposed to study the transmission dynamics and prevalence of HBV infection in mainland China.  
They assumed that the newborns to carrier mothers infected at birth do not stay in a latent period, so that they 
instantaneously become carriers. However, as pointed out by Anderson and May (1991) and White and Fenner 
(1994), an HBV carrier must have harboured the virus in the blood for at least six months. By this newborns to 
carrier mothers infected at birth are latently infected individuals. Mehmood (2011) supported the same view in 
his study and assumed that the proportion of the infected newborns to carrier mothers is latent. The role of 
treatment of HBV carriers as a measure of control was not considered in their model. 
In this paper, the impact of vaccination and treatment on HBV transmission dynamics is investigated.  We also 
assume that the proportion of the newborns to carrier mothers infected at birth are latently infected individuals 
and, therefore, shall include them in the latent compartment.  
The plan of this paper is as follows. The model equations are formulated in section 2. Section 3 is devoted to 
sensitivity analysis of the basic reproduction number. Numerical simulations of the model are treated in section 
5. Section 5 gives the discussion of the results. Conclusive remarks are passed in section 6. 
 2.  Formulation of the Model Equations 
  2.1. The Existing Model 
We begin our model formulation by introducing the model by Zou et al (2009).  We, first, present the parameters 
and assumptions of the existing model.  
2.2. Assumptions of the Existing model 
The following are the assumptions of the existing model by Zou et al (2009): 
(i) The population is compartmentalized into the proportions of  susceptible individuals ,  latent 
individuals  acutely infected individuals  chronic carriers  vaccinated 
individuals  and the recovered individuals  all at time  
(ii) The population is homogeneous, 
(iii) Influx into the population is by birth only, 
(iv) Exit out of the population is by natural and HBV-related mortality only, 
(v) The vaccinated individuals do not acquire permanent immunity, 
(vi) The newborns to carrier mothers infected at birth proceed to carrier state immediately.  
   2.3. Variables and Parameters of the Existing Model 
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The population is partitioned into six compartments described as follows:  proportion of the susceptible 
individuals at time  
 proportion of the latent individuals at time  
proportion of the acutely infected individuals at time  
 proportion of the chronic carriers at time  
 proportion of the recovered individuals at time  
 proportion of the vaccinated individuals at time  
The following are the parameters of the existing model: 
birth rate, 
=natural mortality rate, 
HBV-related mortality rate, 
proportion of births without vaccination, 
proportion of births vaccinated, 
proportion of births vertically infected, 
rate of waning vaccine-induced immunity, 
rate of moving from latent state to acute state, 
transmission coefficient, 
ate of moving from acute to other compartments, 
average probability that an individual fails to clear an acute infection and develops to carrier state, 
 rate of moving from acute to carrier, 
rate of moving from acute to recovered class, 
ate of moving from carrier to immune, 
vaccination rate of the susceptible individuals, 
 reduced transmission rate relative to acute infection by carriers. 
The following is a flow diagram for the existing model. 
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2.4. The Equations of the Existing Model 
Using the above assumptions, parameters and flow diagram, Zou et al (2009) derived the following model 
equations. 
 
 
 
 
 
 
2.5The Extended Model  
We shall use the following assumptions and flow diagram to derive the extended model used in this work. 
 2.6. Assumptions of the Extended Model 
In addition to the assumptions by Zou et al (2009), we make the following assumptions: 
     (i)       The chronic carriers are treated at the rate  Acute infections are not subjected to antiviral treatment 
because of possibility of relapse and resistance (WHO, 2001), 
(ii) The newborns to carrier mothers infected at birth, first, enter the latent class (Mehmood, 2011), 
(iii) The treated individuals recover (O’Leary et al, 2008).  
  
 
 
 
 
Figure 1: Flow diagram of HBV transmission dynamics for the existing model 
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The flow diagram for the existing model is now amended to obtain the flow diagram for the extended model as 
follows: 
 
2.7. Equations of the Extended Model 
The infected newborns are now moved to the second equation instead of the fourth equation in the existing 
model. Also, chronic individuals are now treated at a rate  and this is incorporated in the last term in the fourth 
equation. 
Based on the above assumptions, parameters and flow diagram, we extend the model by Zou et al (2009) as 
follows. 
 
 
 
 
 
 
  
 
Because the models are in terms of proportions,  
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Figure 2: Flow diagram of HBV transmission dynamics for the extended model 
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  for all time   
The model is defined in the subset  of , where 
 
Table1: Parameter values used in numerical simulations 
Parameter/Variable Value Reference 
v
 0.11 Zou et al (2009) 
 0.1 Zou et al (2009) 

 
6 per year Zou et al (2009)
 

 
0.95 Zou et al (2009)
 

1  
4 per year Zou et al (2009)
 
q
 0.885 Zou et al (2009) 

2  
0.025 Zou et al (2009)
 

 0.16 Zou et al (2009)   0.0367 USAID (2009) 

0
 0.0166 USAID (2009) 
)0(S  0.7 Assumed 
)0(L  0.05 Assumed 
)0(I  0.05 Assumed 
)0(C  0.08 Olumuyiwa et al (2011) 
)0(R  0.12 Assumed 
 
 3.1. Sensitivity Analysis of the Basic Reproduction Number,   
We now calculate the disease-free equilibrium state of the extended model. As done in Zou et al (2009), we 
begin this by setting the left hand sides of equations  to zero and get the disease-free equilibrium 
state as follows. 
The disease-free equilibrium state,  , where  and  
Next generation method gives the basic reproduction number as follows. 
  
 leads to the following results. 
 Proposition 3.1   is a strictly decreasing function of  
This is proved numerically as follows. 
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Proposition 3.2  is a strictly decreasing function of  
The numerical proof is shown below. 
 
 
Proposition 3.3   is strictly decreasing on  
See the proof in the sequel. 
Figure 3: Impact of vaccination of susceptible individuals on the basic reproduction 
number. Other parameter values are as in Table 1. 
Figure 4: Impact of treatment on the basic reproduction number. Other parameter 
values are as in Table 1. 
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4.1 Numerical Simulations of the Model 
Our numerical results are obtained from the numerical experiments performed in this section. Therefore, in this 
section, we carry out numerical simulations of the extended model. The aim of these simulations is to 
demonstrate numerically the feasibility of control of HBV transmission using vaccination and treatment 
parameters. To achieve this, the order four Runge-Kutta algorithm was coded in MATLAB to integrate our 
extended model. The values of our model parameters are based on published epidemiological data shown in 
Table 1 above. The target population for our numerical simulations is Nigeria population, and the vital statistics 
were obtained from USAID (2009), Abraham (2004), WHO (2001), Salawu et al (2010) and Olumuyiwa et al 
(2011).  
 
 
 
 
 
  
 
 
 
Figure 6: Graph showing the prevalences for acutely infected individuals and chronic 
carriers without any control measure.  All other 
parameter values are as in Table 1. 
Figur  5: Impact of newborn vaccination on the basic reproduction number. Other 
parameter values are as in Table 1. 
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Figure 7: Graph showing the prevalences for acutely infected individuals and chronic 
carriers with high treatment rate  and no vaccination (  All 
other parameter values are as in Table 1. 
 
 
 
Figure 8: Graph showing the prevalences for acutely infected individuals and chronic 
carriers with a very high treatment rate  and no vaccination 
(    All other parameter values are as in Table 1. 
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Figure 9: Graph showing the prevalences for acutely infected individuals and chronic 
carriers with high vaccination rate  and no treatment (    All 
other parameter values are as in Table 1. 
  
 
 
 
Figure 10: Graph showing the prevalences for acutely infected individuals and chronic carriers 
with a very high vaccination rate  and no treatment (    All 
other parameter values are as in Table 1. 
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Figure 11: Graph showing the prevalences for acutely infected individuals and chronic 
carriers with high vaccination rate  and low treatment 
(   All other parameter values are as in Table 1. 
  
 
 
 
Figure 12: Graph showing the prevalences for acutely infected individuals and chronic 
carriers with high vaccination rate  and high treatment 
(  All other parameter values are as in Table 1. 
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5.1 DISCUSSION 
In this study, we extended and analyzed a mathematical model for the transmission dynamics of HBV infection 
considering vaccination and treatment as control measures. The model is presented in section 2.  The numerical 
results are presented in the subsequent sections.  
The results of our numerical experiments with the model are discussed as follows. The parameter values are as 
shown in Table 1.  
 The vaccination parameters  and  and the treatment parameter  have important effects on the 
basic reproduction number, . Therefore,  was numerically explored for its sensitivity to the vaccination 
rate of the susceptible individuals , the proportion of the newborns vaccinated  and the treatment 
rate   
Figures 3, 4 and 5 show that  is a decreasing function of   and  Figure 3 shows that minimum 
vaccination rate of 0.16 of susceptible individuals can reduce  below unity while Figures 4 and 5 show that 
minimum treatment rate of 0.04 and minimum newborn vaccination rate of 0.6 each can achieve the same 
purpose. This shows that the treatment parameter is relatively the most sensitive and important parameter in 
controlling HBV infection (Medley, 2001; O’Leary, 2008).  
The results of the numerical simulations of the extended model are discussed below.  The parameter values are 
as shown in Table 1. The main aim is to assess the feasibility of control and eradication of HBV infection for 
different values of vaccination and treatment parameters. Figure 6 shows the prevalence of HBV infections in 
absence of any intervention (  It shows that prevalence of HBV infection 
increases to a peak, decreases and remains almost stable through the horizon at an alarming rate. The peak 
indicates the highest point of the epidemic and the almost stable horizon indicates endemicity of the HBV 
infection. This study confirms that without any intervention, the disease cannot be eradicated. 
Figures 7 shows decreasing prevalence of HBV carriers when treatment rate is high  and no 
vaccination (   It shows a sharp rise of the prevalence of the acutely infected 
  
 
 
 
Figure 13: Graph showing the prevalences for acutely infected individuals and chronic 
carriers with a very high vaccination rate  and a very high 
treatment rate (  All other parameter values are as in Table 1. 
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individuals for a short while because of the pool of latently infected individuals progressing to the acute 
compartment. The Figure shows that with high treatment rate, the disease can be eradicated in the long run.   
Similarly, Figure 8 shows more decreasing prevalence of HBV carriers when treatment rate is very high 
 and no vaccination (   In the same vein, a sharp rise of the prevalence of 
the acutely infected individuals occurs for a short while because of the pool of latently infected individuals 
progressing to the acute compartment. With a very high treatment rate, the disease can be eradicated in the long 
run. Thus, this study confirms that effective treatment can be a useful intervention for the control and eradication 
of HBV.    
Figure 9 shows that there is a sharp rise in the prevalences of both carriers and acutely infected individuals for a 
short while, followed by an exponential decay after a long time to zero when vaccination rate is high 
and no treatment    Also, this Figure shows that with high 
vaccination rate, the disease be eradicated. Also, Figure 10 shows that there is a sharp rise in the prevalences of 
both carriers and acutely infected individuals for a short while, followed by an exponential decay after a long 
time to zero when vaccination rate is very high and no treatment    
Also, this Figure shows that with a very high vaccination rate, the disease be eradicated faster. Hence, this study 
ascertains that effective vaccination can be a useful intervention for the control and eradication of HBV.   
However, it can be inferred from Figures 7, 8, 9 and 10 that treatment as a control strategy reduces the 
prevalence and eradicates the disease faster than vaccination, making treatment a relatively more useful 
intervention (Medley, 2001; O’Leary, 2008).  
 Figure 11 shows decreasing prevalence of HBV infection with high vaccination rate 
and low treatment rate (  combined, although there is a sharp rise in 
the prevalence of latently infected individuals because of the pool of latently infected individuals before 
intervention commences. This study shows that with a combination of high vaccination rate and low treatment 
rate, the disease can be eradicated within a shorter period than only vaccination. 
Figures 12 shows rapid decreasing prevalence of HBV infection with high vaccination rate 
 and high treatment rate  combined. This Figure shows that with a 
combination of high vaccination rate and high treatment rate, the disease can be eradicated in the shortest 
possible time.  Similarly, Figure 13 shows the most rapid decreasing prevalence of HBV infection with a very 
high vaccination rate  and a very high treatment rate  combined. In 
the same vein, this Figure shows that with a combination of a very high vaccination rate and a very high 
treatment rate, the disease be eradicated in the shortest possible time.  Thus, this study confirms that a 
combination of vaccination and treatment as a control strategy is the most effective for the control and 
eradication of HBV infection.  
6. CONCLUSION AND RECOMMENDATIONS 
 
6.1 Conclusion 
 
In this study, we extended and studied a mathematical model for the transmission dynamics of HBV infection 
considering vaccination and treatment as control measures in the host population. The model parameters are 
given in Section (2). The model was derived with the aid of a flow diagram in Figure 2. The disease-free 
equilibrium state of the model was determined.  The basic reproduction number,  for the model was computed 
using the next generation method.  was numerically evaluated for its sensitivity to the vaccination rate of the 
susceptible individuals, the proportion of the newborns vaccinated and the treatment rate. The model was solved 
numerically by Runge-Kutta method of order four in MATLAB.  
Our numerical results reveal that  is a decreasing function of the vaccination rate, the newborn vaccination 
rate and treatment rate. Thus, increasing the vaccination and treatment rates reduces  
Numerical simulations of the model show that effective vaccination or treatment is a good control strategy for 
HBV infection. However, a combination of vaccination and treatment is a better control strategy for the disease.   
6.2 Recommendations 
Based on the findings in this study, we make the following recommendations. 
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(1) The Governments and stakeholders should consider using a combination of effective vaccination and 
treatment  as a control strategy on HBV control programmes. 
(2) Vaccination of every individual susceptible to HBV and treatment of every individual chronically 
infected with HBV may be impossible because of resources. However, this study gives threshold 
values for vaccination and treatment to be used for optimal results. 
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